Ultrastructural alterations of endothelium covering advanced atherosclerotic plaque in human carotid artery visualised by scanning electron microscope

Journal of Physiology and Pharmacology

Volumn 53, Issue 4 I, 2002, Pages 713-723

  Walski, M ^a,d   Chlopicki, S ^b   Celary Walska, R ^c   Frontczak Baniewicz, M ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c Ministry of Interior and Administration Republic of Poland Central Clinical Hospital   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Atherosclerosis; Carotid artery; Endothelium; Scanning electron microscope

Indexed keywords

COLLAGEN FIBRIL; FIBRIN;

ADULT; AGED; ARTERY ENDOTHELIUM; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONFERENCE PAPER; ENDARTERECTOMY; ENDOTHELIUM LESION; FEMALE; HUMAN; HUMAN TISSUE; INTERNAL CAROTID ARTERY; LEUKOCYTE ADHERENCE; MALE; MICROVILLUS; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ADHESION;

AGED; ARTERIOSCLEROSIS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED;

EID: 12244270367     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Drexler H, Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999;31:51-60.
2. Quyyumi AA. Endothelial function in health and disease: New insights into the genesis of cardiovascular disease. Am J Med 1998;105(1A):32S-395.
3. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-2678.
4. Raitakari OT, Celermajer DS. Testing for endothelial dysfunction. Ann Med 2000;32:293-304.
5. Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002;105:546-549.
6. Ross R, Glomset J, Harker L. Response to injury and atherogenesis. Am J Pathol 1977;86:675-684.
7. Gimbrone MA, Jr. Endothelial dysfunction, hemodynamic forces, and atherosclerosis. Thromb Haemost 1999;82:722-726.
8. Gryglewski RJ, Dembinska-Kiec A, Zmuda A, Gryglewska T. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis 1978;31:385-394.
9. Newby DE, McLeod AL, Uren NG et al. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: Direct link between endothelial dysfunction and atherothrombosis. Circulation 2001;103:1936-1941.
10. Juhan-Vague I, Alessi MC, Joly P et al. Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response. Arteriosclerosis 1989;9:362-367.
11. Schumacher A, Seljeflot I, Sommervoll L et al. Increased levels of endothelial haemostatic markers in patients with coronary heart disease. Thromb Res 2002;105:25-31.
12. Lerman A, Holimes DR, Jr., Bell MR et al. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995;92:2426-2431.
13. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001;89:763-771.
14. De Meyer GR, Hoylaerts MF, Kockx MM et al. Intimal deposition of functional von Willebrand factor in atherogenesis. Arterioscler Thromb Vasc Biol 1999;19:2524-2534.
15. Kockx MM, De Meyer GR, Buyssens N et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res 1998;83:378-387.
16. Taylor KE, Glagov S, Zarins CK. Preservation and structural adaptation of endotheliurn over experimental foam cell lesions. Quantitative ultrastructural study. Arteriosclerosis 1989;9:881-894.
17. Burrig KF. The endothelium of advanced arteriosclerotic plaques in humans. Arterioscler Thromb 1991;11:1678-1689.
18. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362(6423):801-809.
19. Brand K, Page S, Rogler G et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 1996;97:1715-1722.
20. Oguogho A, Sinzinger H. Isoprostanes in atherosclerosis. J Physiol Pharmacol 2000;51:673-682.
21. Beltowski J, Wojcicka G, Mydlarczyk M, Jamroz A. The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity. J Physiol Pharmacol 2002;53:463-475.
22. Hutcheson IR, Smith JA, Griffith TM. Abolition of flow-dependent EDRF release before that evoked by agonists in hypercholesterolaemic rabbits. Br J Pharmacol 1994;113:190-144.
23. Scalia R, Appel JZ, III, Lefer AM. Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: Role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol 1998;18:1093-1100.
24. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15:551-561.
25. Davies MJ. Stability and instability: Two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 1996;94:2013-2020.
26. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
27. Mallat Z, Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res 2001;88:998-1003.
28. Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 1992;86:723-729.
29. Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest 1986;54:295-303.